IP Library Granted Patent US 12,291,740
Granted Patent B2
US 12,291,740 · App. 15/124,977 · Granted May 6, 2025

Detection of target nucleic acid sequences using different detection temperatures

Inventors: Jong Yoon Chun (Seoul, KR); Young Jo Lee (Seoul, KR)
Assignee: SEEGENE, INC.
C12Q1/6816C12Q1/6827C12Q1/6858G01N25/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,291,740
App. No.
15/124,977
Granted
May 6, 2025
Kind
B2
Abstract

The present invention relates to detection of target nucleic acid sequences using different detection temperatures. The present invention employing different detection temperatures enables to detect a plurality of target nucleic acid sequences in conventional real-time manners even with a single type of label in a single reaction vessel. The conventional technologies detect a plurality of target nucleic acid sequences by a melting analysis after target amplification. Unlikely, the present invention does not require a melting analysis after target amplification, such that the time for analysis is greatly reduced.

Claims (13)

1. A method for detecting two target nucleic acid sequences in a sample using different detection temperatures, comprising:

(a) incubating the sample with two signal-generating means for detection of the two target nucleic acid sequences in a single first reaction vessel and detecting a generated signal by using a single type of detector; wherein the two target nucleic acid sequences are known; wherein each of the target nucleic acid sequences is detected by a corresponding signal-generating means; wherein each of the two signal-generating means comprises an oligonucleotide with a fluorescent label and when each of the two signal-generating means comprises primers and probes, the nucleotide sequences of the primers and probes are designed not to bind to each other; wherein one of the two target nucleic acid sequences has a high detection temperature and the other has a low detection temperature determined by the corresponding signal-generating means; wherein the signal-generating means for the target nucleic acid sequence having the high detection temperature generates a signal at the high detection temperature and at the low detection temperature, dependently on the presence of the target nucleic acid sequence having the high detection temperature, and the signal-generating means for the target nucleic acid sequence having the low detection temperature generates a signal at the low detection temperature, dependently on the presence of the target nucleic acid sequence having the low detection temperature; wherein the high detection temperature is a temperature at which a signal is generated from the signal-generating means for the target nucleic acid sequence having the high detection temperature, and the low detection temperature is a temperature at which a signal is generated from the two signal-generating means; wherein the wavelengths of signals to be generated by the two signal-generating means are not differentiated by the single type of detector; wherein the detection is performed only at both the high detection temperature and the low detection temperature at each cycle, selected several cycles or end-point of real-time PCR (polymerase chain reaction) and wherein the two target nucleic acid sequences are amplified; and

(b) determining the presence of the two target nucleic acid sequences by the signals detected in the step (a); wherein (i) the presence of the target nucleic acid sequence having the high detection temperature is determined by the signal detected at the high detection temperature and (ii) the presence of the target nucleic acid sequence having the low detection temperature is determined by comparing a difference between the signal intensity detected at the high detection temperature and the signal intensity detected at the low detection temperature with a threshold, wherein the difference is calculated by multiplying the signal detected at the high detection temperature by a reference value and then subtracting the multiplication result from the signal detected at the low detection temperature, wherein the reference value is obtained by (i) subjecting the target nucleic acid sequence having the high detection temperature to real-time PCR using the signal-generating means for the target nucleic acid sequence having the high detection temperature in a second reaction vessel other than the first reaction vessel in the step (a), (ii) detecting signals only at the high detection temperature and the low detection temperature in each cycle, selected several cycles or end-point of real-time PCR, and (iii) then obtaining a ratio of the signal detected at the low detection temperature to the signal detected at the high detection temperature;

wherein the method does not comprise a melting curve analysis.

2. The method according to claim 1 , wherein the signal-generating means for each of the target nucleic acid sequences are a signal-generating means to generate a signal in a dependent manner on the formation of a duplex.

3. The method according to claim 1 , wherein the signal-generating means for each of the target nucleic acid sequences are a signal-generating means by formation of a duplex in a dependent manner on cleavage of a mediation oligonucleotide having 15-150 nucleotides specifically hybridized with the target nucleic acid sequence.

4. The method according to claim 1 , wherein the signal-generating means for the target nucleic acid sequence having the high detection temperature is a signal-generating means by cleavage of a detection oligonucleotide having 5-100 nucleotides by an enzyme having 5′-nuclease activity, and the signal-generating means for the target nucleic acid sequence having the low detection temperature is a signal-generating means by the formation of a duplex.

5. The method according to claim 1 , wherein the signal-generating means for the target nucleic acid sequence having the high detection temperature is a signal-generating means by cleavage of a detection oligonucleotide having 5-100 nucleotides by an enzyme having 5′ nuclease activity, and the signal-generating means for the target nucleic acid sequence having the low detection temperature is a signal-generating means by formation of a duplex in a dependent manner on cleavage of a mediation oligonucleotide having 15-150 nucleotides specifically hybridized with the target nucleic acid sequence.

6. The method according to claim 1 , wherein the two signal-generating means comprise an identical label and the wavelengths of signals from the label are not differentiated by the single type of detector.

7. The method according to claim 1 , wherein when the signal is not detected at the high detection temperature, the determination of the presence of the target nucleic acid sequence having the low detection temperature is made by the signal detected at the low detection temperature.

8. The method according to claim 1 , wherein when the target nucleic acid sequence having the high detection temperature is present, the presence of the target nucleic acid sequence having the low detection temperature is determined by calculating the difference with a reference value.

9. The method according to claim 8 , wherein the reference value, is obtained by (i) incubating the target nucleic acid sequence having the high detection temperature with a signal-generating means for detection of the target nucleic acid sequence having the high detection temperature in a second reaction vessel other than the first reaction vessel in the step (a), (ii) detecting signals at both the high detection temperature and the low detection temperature, and (iii) then obtaining a difference between the signal detected at the high detection temperature and the signal detected at the low detection temperature.

10. The method according to claim 1 , wherein the two target nucleic acid sequences comprise a nucleotide variation and one of the two target nucleic acid sequences comprises one type of the nucleotide variation and the other comprises the other type of the nucleotide variation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2016
From: CHUN, JONG YOON; LEE, YOUNG JO
To: SEEGENE, INC.
Reel/Frame 039690/0228 →
Priority Claims (3)
KR 10-2014-0037310 · Mar 28, 2014 · national
WO PCT/KR2014/004173 · May 9, 2014 · international
WO PCT/KR2014/006714 · Jul 23, 2014 · international
Continuity (2)
Provisional Application 61979545 · Apr 15, 2014
Related Publication 20170247750A1 · Aug 31, 2017
References Cited (62)
US 5538848A · Livak et al. · 1996 [cited by applicant]
US 6444661B1 · Barton · 2002 [cited by examiner]
US 9284607B2 · Fu · 2016 [cited by applicant]
US 9540681B2 · Chun et al. · 2017 [cited by applicant]
US 10752938B2 · Chun · 2020 [cited by examiner]
US 11859243B2 · Chun · 2024 [cited by examiner]
US 20020065609A1 · Ashby · 2002 [cited by examiner]
US 20050053950A1 · Ubani et al. · 2005 [cited by applicant]
US 20070031829A1 · Yasuno · 2007 [cited by examiner]
US 20070042400A1 · Choi · 2007 [cited by examiner]
US 20070042419A1 · Barany · 2007 [cited by examiner]
US 20110244460A1 · Hirai et al. · 2011 [cited by examiner]
US 20120014977A1 · Furihata · 2012 [cited by examiner]
US 20120116686A1 · Palais · 2012 [cited by applicant]
US 20120253689A1 · Rogan · 2012 [cited by examiner]
US 20140057263A1 · Engel · 2014 [cited by examiner]
US 20140057264A1 · Chun · 2014 [cited by examiner]
US 20170027750A1 · Wiley · 2017 [cited by applicant]
US 20170362646A1 · Chun et al. · 2017 [cited by applicant]
US 20180057868A1 · Walder · 2018 [cited by examiner]
JP 2004533801A · 2004 [cited by applicant]
JP 2012513215A · 2012 [cited by applicant]
JP 2013540449A · 2013 [cited by applicant]
JP 2013538041A · 2013 [cited by applicant]
WO 2006044994A2 · 2006 [cited by applicant]
WO 2010013017A1 · 2010 [cited by applicant]
WO 2010017543A1 · 2010 [cited by applicant]
WO 2010068576A1 · 2010 [cited by applicant]
WO 2010104768A1 · 2010 [cited by applicant]
WO 2011019837A1 · 2011 [cited by applicant]
WO 2012048207A2 · 2012 [cited by applicant]
WO 2012096523A2 · 2012 [cited by applicant]
WO 2013115442A1 · 2013 [cited by applicant]
WO 2013133561A1 · 2013 [cited by applicant]
WO 2014022827A1 · 2014 [cited by applicant]
WO 2015147370A1 · 2015 [cited by applicant]
“Oligonucleotide definition,” Merriam-Webster.com; accessed Aug. 23, 2017. (Year: 2017). [cited by examiner]
Forster et al., “A human gut bacterial genome and culture collection for improved metagenomic analyses”, Nature Biotechnology, vol. 37, Feb. 2019, pp. 186-192. (Year: 2019). [cited by examiner]
Teixeira and Cooper, “Using hominin introgression to trace modern human dispersals”, PNAS, Jul. 30, 2019, vol. 116, No. 31, 15327-15332. (Year: 2019). [cited by examiner]
Forster et al., “A human gut bacterial genome and culture collection for improved metagenomic analyses”, Nature Biotechnology, vol. 37, Feb. 2019, 186-192. (Year: 2019). [cited by examiner]
Zhu et al., “A Novel Coronavirus from Patients with Pneumonia in China, 2019”, The New England Journal of Medicine, vol. 382, Jan. 2020, pp. 727-733. (Year: 2020). [cited by examiner]
Kim et al., “The Architecture of SARS-CoV-2 Transcriptome”, Cell, vol. 181, May 14, 2020, pp. 914-921. (Year: 2020). [cited by examiner]
“List of sequenced bacterial genomes”, Wikipedia.com; accessed Jan. 24, 2014. (Year: 2014). [cited by examiner]
“Fungi,” Wikipedia.com; accessed Jun. 3, 2013. (Year: 2013). [cited by examiner]
“How many species of bacteria are there”, wisegeek.com; accessed Jan. 21, 2014. (Year: 2014). [cited by examiner]
“Viruses”, Wikipedia.com, accessed Nov. 24, 2012. (Year: 2012). [cited by examiner]
“Plant,” Wikipedia.com; accessed Aug. 28, 2015. (Year: 2015). [cited by examiner]
“Mammal,” Wikipedia.com; accessed Sep. 22, 2011. (Year: 2011). [cited by examiner]
“Murinae,” Wikipedia.com, accessed Mar. 18, 2013. (Year: 2013). [cited by examiner]
“Fish,” Wikipedia.com, accessed Nov. 2, 2014. (Year: 2014). [cited by examiner]
“Archaea,” Wikipedia.com, accessed May 11, 2016. (Year: 2016). [cited by examiner]
“Algae,” Wikipedia.com, accessed Mar. 4, 2016. (Year: 2016). [cited by examiner]
“Protozoa,” Wikipedia.com, accessed May 11, 2016. (Year: 2016). [cited by examiner]
“A Timeline of COVID-19 Variants”, Team Verywell Health, Dec. 19, 2023, pp. 1-12. (Year: 2023). [cited by examiner]
“The complete sequence of a human Y chromosome”, Rhe et al., Nature, vol. 621, Sep. 14, 2023, p. 3444. (Year: 2023). [cited by examiner]
Sanchez, J. Aquiles, et al., Two-temperature LATE-PCR endpoint genotyping, BMC Biotechnology 2006, vol. 6, No. 44, pp. 1-14. [cited by applicant]
Gundry, Cameron N., et al., Amplicon Melting Analysis with Labeled Primers; A Closed-Tube Method for differentiating Homozygotes and Heterozygotes, Clinical Chemistry, 2003, vol. 49, No. 3, pp. 396-406. [cited by applicant]
Huang, Qiuying, et al., Multiplex Fluorescence Melting Curve Analysis for Mutation Detection with Dual-Labeled, Self-Quenched Probes, PLos ONE, Apr. 2001, vol. 6, Issue 4, pp. 1-9. [cited by applicant]
Chakravorty, S., et al.; Rapid Detection of Fluoroquinolone-Resistant and Heteroresistant Mycobacterium tuberculosis by Use of Sloppy Molecular Beacons and Dual Melting-Temperature Codes in a Real-Time PCR Assay; Journa… [cited by applicant]
Liu, Q., et al.; Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction; Journal of Antimicrobial Chemotherap… [cited by applicant]
Pierce, K., et al.; Rapid detection and identification of hepatitis C virus (HCV) sequences using mismatch-tolerant hyridization probes: A general method for analysis of sequence variation; Reports, 2013, vol. 55, No. 3… [cited by applicant]
Alvandi, E., et al.; Zip nucleic acid: a new reliable method to increase the melting temperature of real-time PCR probes; Journal of Diabetes & Metabolic Disorders, 2014, vol. 13, pp. 1-4. [cited by applicant]